Breath Test System - Nitric Oxide (NO) Detection

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

System for detecting nitric oxide and carbon dioxide levels in human breath samples. Supports both oral and nasal breathing modes with measurement range of 1ppb to 3500ppb. Used for non-invasive monitoring of respiratory and circulatory parameters.

A breath analysis diagnostic system for measuring fractional exhaled nitric oxide levels, used to assess airway inflammation in respiratory diseases such as asthma. The platform integrates proprietary smart chip, smart algorithm, and smart manufacturing technologies for clinical and home-based testing.

A fluorescent probe for detection and measurement of nitric oxide in biological samples. Enables assessment of NO-mediated signaling and endothelial function.

A device specialized in detecting and measuring biomarkers present in exhaled breath. This technology identifies specific compounds in exhaled air to provide diagnostic information about patient health conditions.

Primary care-based exhaled nitric oxide (FeNO) detection system for guiding drug selection assessment and evaluating therapeutic efficacy. Enables combined or self-testing of exhaled nitrogen oxide to assess airway inflammation and dysbiosis markers in grassroots medical settings.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

Hospital-based exhaled nitric oxide (FeNO) detection system designed for patients with complications and critical illnesses. Enables multi-molecular, multi-airway exhaled gas combined testing to assess airway inflammation and dysbiosis markers for respiratory system disease precision medicine.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

A breath testing device designed for clinics, pharmacies, health screening centers, nursing homes, and community settings. It uses the same gas detection technology as hospital systems with interconnected diagnostic and treatment services, enabling hierarchical diagnosis and treatment of chronic respiratory diseases and cardiopulmonary health screening. It provides FeNO/CaNO/FeCO/FnNO testing for cough and asthma patients to optimize medication selection, reduce acute exacerbations and emergency hospitalization, and for susceptible populations for risk warning and disease prevention.

Reagent strips for detection of nitric oxide levels in biological samples. Used for assessment of vascular and metabolic function.

A home-use breath analyzer designed for patients with chronic respiratory diseases and susceptible populations, featuring a mobile application and detection diagnostic treatment service card. It offers FeNO/FnNO self-testing capabilities using hospital-grade gas detection technology with interconnected diagnostic services, enabling chronic respiratory disease patients to reduce acute exacerbations and emergency hospitalization, and susceptible populations to reduce disease development risk.